Financials in USD. Standardized financial statements.
A compact view of how Volpara Health Technologies Limited turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|
| Revenue? | $32.77M | $24.27M | $18.13M | $12.32M | $5.48M | $2.64M | $1.68M |
| Revenue Growth? | +35.0% | +33.9% | +47.1% | +124.8% | +107.5% | +57.3% | 0.0% |
| Cost of Revenue? | $2.47M | $2.13M | $1.55M | $1.73M | $835,089 | $779,635 | $621,004 |
| Gross Profit? | $30.30M | $22.14M | $16.57M | $10.59M | $4.65M | $1.86M | $1.06M |
| Gross Margin? | +92.5% | +91.2% | +91.4% | +86.0% | +84.8% | +70.5% | +63.0% |
| Operating Expenses? | $48.42M | $44.50M | $38.63M | $37.32M | $16.70M | $11.11M | $9.94M |
| Operating Income? | -$10.30M | -$14.88M | -$17.26M | -$21.64M | -$11.20M | -$8.28M | -$8.74M |
| EBITDA? | -$6.83M | -$13.85M | -$16.67M | -$19.49M | -$11.85M | -$8.22M | -$9.11M |
| Income Before Tax | -$10.65M | -$15.01M | -$17.40M | -$21.71M | -$11.26M | -$8.28M | -$8.74M |
| Income Tax Expense | -$1.48M | $266,753 | -$1.34M | -$1.89M | -$11,492.051 | $665,977 | -$121,461.187 |
| Net Income? | -$9.17M | -$15.28M | -$16.05M | -$19.83M | -$11.24M | -$8.28M | -$8.74M |
| EPS? | $-0.04 | $-0.06 | $-0.06 | $-0.09 | $-0.06 | $-0.06 | $-0.07 |
| Diluted EPS? | $-0.04 | $-0.06 | $-0.06 | $-0.09 | $-0.06 | $-0.06 | $-0.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality